Slaughter and May, Hong Kong, advised Credit Suisse (Hong Kong) Limited, as manager, in relation to the HK$624.7 million secondary block trade of shares in Xiabuxiabu Catering Management (China) Holdings Co., Ltd. (Xiabuxiabu Catering Management) held by General Atlantic Singapore Fund Pte. Ltd. The block trade represents approximately 6% of the issued share capital of Xiabuxiabu Catering Management.

Clifford Chance advised GSO Capital Partners LP (“GSO”), the global credit investment platform of The Blackstone Group L.P., on the fundraising of an opportunistic credit fund, GSO Diamond Portfolio Fund. The fundraising process took less than two months and resulted in a "one and done" fund closing on approximately US$950 million in capital commitments.

Osborne Clarke has advised the shareholders of Catalyst Development, a specialist financial markets consultancy, on an investment from Livingbridge, one of the UK’s leading mid-market private equity investors.

Mishcon de Reya's Corporate department advised Boom Cycle, London's leading indoor cycling studio group, on an expansion capital investment round from a syndicate of growth capital investors.

Over the next few years, Boom Cycle is planning to expand rapidly from their first locations in Shoreditch and Holborn to multiple sites around London.

Clifford Chance advised Griffis Residential on its first institutional capital raise, Griffis Premium Apartment Fund IV, which raised $407 million and closed on September 1, 2017. Griffis Residential’s new multifamily fund beat its target by more than $100 million.

De Brauw has adviced Odfjell Terminals B.V. on the sale of its shares in Singapore Tank Terminal.

Nature of transaction
Odfjell Terminals B.V. has entered into an agreement with a fund managed by Macquarie Infrastructure and Real Assets to sell its 50% ownership in Oiltanking Odfjell Terminal Singapore Pte Ltd for a price around USD 300 million. This implies an enterprise value of around USD 330 million for Odfjell Terminals B.V.’s share in the Singapore terminal.
Value of transaction
USD 330 million
De Brauw involvement

The Firm acted as counsel for Lexington Partners, as lead investor, in a $1.2 billion secondary acquisition of a strip of approximately 20% of the investments in 29 Asian-based portfolio companies of Warburg Pincus Private Equity XI L.P. An affiliate of Warburg Pincus will continue to manage the investments in these portfolio companies. The transaction is one of the largest secondary acquisitions involving Asian private equity-backed companies.

Orrick advised Süd Beteiligungen GmbH (SüdBG) on a capital increase and participation in Janoschka Group. As a new shareholder, the Stuttgart-based in-vestment company supports the planned further growth of the internationally active group of companies.

SüdBG is a wholly-owned subsidiary of Landesbank Baden-Württemberg (LBBW) and supports fast-growing medium-sized enterprises with equity and mezzanine solutions with a focus on growth financing and business succession.

Immatics Biotechnologies, a biotech firm with sites in Tübingen, Munich and Houston, has completed its Series E round of financing, raising a total of USD 58 million. The existing life science investors, which include dievini Hopp BioTech holding and Wellington Partners, have now been joined by Amgen, a world-leading biotechnology company and strategic partner of Immatics.

International law firm McDermott Will & Emery has advised Antabio SAS (“Antabio”), a biopharmaceutical company developing novel antibacterial treatments in areas of highest unmet needs, in relation to a €7.3M series-A financing with subscriptions from investment funds iXO Private Equity, IRDI SORIDEC Gestion, Galia Gestion and from the company’s historical investors including former President of OM Pharma Christophe Ricard.